ZAI LAB LTD0000006 (1ZLB) - Total Liabilities

Latest as of March 2026: €433.76 Million EUR ≈ $507.11 Million USD

Based on the latest financial reports, ZAI LAB LTD0000006 (1ZLB) has total liabilities worth €433.76 Million EUR (≈ $507.11 Million USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore ZAI LAB LTD0000006 annual equity growth to track the company's year-over-year net asset growth rate.

ZAI LAB LTD0000006 - Total Liabilities Trend (2021–2025)

This chart illustrates how ZAI LAB LTD0000006's total liabilities have evolved over time, based on quarterly financial data.

ZAI LAB LTD0000006 Competitors by Total Liabilities

The table below lists competitors of ZAI LAB LTD0000006 ranked by their total liabilities.

Company	Country	Total Liabilities
KPIT Technologies Limited NSE:KPITTECH	India	Rs34.69 Billion
Meta Financial Group Inc NASDAQ:CASH	USA	$6.26 Billion
Austevoll Seafood ASA OL:AUSS	Norway	Nkr24.24 Billion
Monadelphous Group Ltd F:8MP	Germany	€421.77 Million
Westone Information Industry Inc SHE:002268	China	CN¥1.57 Billion
Pharvaris BV NASDAQ:PHVS	USA	$26.66 Million
SK Bioscience Co Ltd KO:302440	Korea	₩847.96 Billion
VIVENDI UNSPON.ARD EO 55 F:VVUD	Germany	€2.25 Billion

Liability Composition Analysis (2021–2025)

This chart breaks down ZAI LAB LTD0000006's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see 1ZLB stock market capitalisation.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	2.40	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.66	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.40	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how ZAI LAB LTD0000006's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for ZAI LAB LTD0000006 (2021–2025)

The table below shows the annual total liabilities of ZAI LAB LTD0000006 from 2021 to 2025.

Year	Total Liabilities	Change
2025-12-31	€456.88 Million ≈ $534.15 Million	+32.49%
2024-12-31	€344.86 Million ≈ $403.17 Million	+43.58%
2023-12-31	€240.18 Million ≈ $280.79 Million	+37.60%
2022-12-31	€174.54 Million ≈ $204.06 Million	-24.11%
2021-12-31	€230.00 Million ≈ $268.89 Million	--

About ZAI LAB LTD0000006

F:1ZLB Germany Biotechnology

Market Cap

$2.06 Billion

€1.76 Billion EUR

Market Cap Rank

#6418 Global

#963 in Germany

Share Price

€1.57

Change (1 day)

+0.00%

52-Week Range

€1.36 - €3.30

All Time High

€152.00